• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about Novo Nordisk A/S

    Recent news which mentions Novo Nordisk A/S

    < Previous 1 2 3 4 5 6 7 Next >
    The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
    Tags Europe Economy ASML Holding NV Retail industry
    From CNBC.com News
    Novo Nordisk and Eli Lilly rival soars 26% after promising test results
    Tags Pharmaceuticals Novo Nordisk A/S Zealand Pharma A/S
    From CNBC.com News
    What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
    Tags Drugs Employee benefits Health care industry
    From CNBC.com News
    Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
    Tags Catalent Inc Companies Breaking news
    From CNBC.com News
    Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
    Tags Companies Breaking news Business
    From CNBC.com News
    Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
    Tags Biotech and Pharmaceuticals Biotechnology Business News
    From CNBC.com News
    Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars
    Tags Investing Breaking News: Investing Novo Nordisk A/S
    From CNBC.com News
    5 things to know before the stock market opens Monday
    Tags General Motors Co Economy Business
    From CNBC.com News
    Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
    Tags Biotech and Pharmaceuticals Biotechnology Business News
    From CNBC.com News
    The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
    Tags Viking Therapeutics Inc US: News Pfizer Inc
    From CNBC.com News
    People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey
    Tags Unilever PLC Investment strategy Mondelez International Inc
    From CNBC.com News
    Biden administration's Medicare drug price negotiations will face major tests in 2024
    Tags Prescription drugs Social issues Novo Nordisk A/S
    From CNBC.com News
    Here are the big health sector themes to watch next year
    Tags Biotech and Pharmaceuticals Qiagen NV Business News
    From CNBC.com News
    Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
    Tags Biotech and Pharmaceuticals Biotechnology Business News
    From CNBC.com News
    5 things to know before the stock market opens Monday
    Tags Technology Business US STEEL DRN
    From CNBC.com News
    The weight loss drug boom isn't over yet — here's what to expect in the year ahead
    Tags Eli Lilly and Co US: News Novo Nordisk A/S
    From CNBC.com News
    Patients regain weight after stopping Eli Lilly's Zepbound, study says
    Tags Novo Nordisk A/S US: News Eli Lilly and Co
    From CNBC.com News
    Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
    Tags Pharmaceuticals Health & Science Novo Nordisk A/S
    From CNBC.com News
    An EU wealth tax and the end of U.S. capitalism: One bank’s ‘outrageous’ predictions for 2024
    Tags Investment strategy World Economy Breaking News: Investing
    From CNBC.com News
    Cramer says the growing popularity of weight loss drugs brings new investing opportunities
    Tags Stock markets Mad Money Jacobs Solutions Inc
    From CNBC.com News
    Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
    Tags Sanofi SA Eisai Co Ltd Science
    From CNBC.com News
    Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
    Tags Pfizer Inc Novo Nordisk A/S Clinical trials
    From CNBC.com News
    Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
    Tags Biotech and Pharmaceuticals Biotechnology Business News
    From CNBC.com News
    Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
    Tags US: News Eli Lilly and Co Novo Nordisk A/S
    From CNBC.com News
    Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
    Tags Business Investment strategy Investment Strategy
    From CNBC.com News
    Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
    Tags Business News Biotechnology Biotech and Pharmaceuticals
    From CNBC.com News
    5 things to know before the stock market opens Monday
    Tags Politics Target Corp Markets
    From CNBC.com News
    Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events
    Tags Pharmaceuticals Health & Science Business
    From CNBC.com News
    Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
    Tags Stock markets Mad Money Eli Lilly and Co
    From CNBC.com News
    Cramer's Lightning Round: Buy AutoZone
    Tags Business News Investment Strategy Investment strategy
    From CNBC.com News
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.